Living

Johnson & Johnson to buy Firefly Bio for $1 billion

By Reuters Reuters
People gather next to a logo of Johnson & Johnson at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov
People gather next to a logo of Johnson & Johnson at the company’s booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov Maxim Shemetov Reuters

Johnson & Johnson said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini Ganguli)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published June 8, 2026 at 7:08 AM.

Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER